Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshio Toyosawa is active.

Publication


Featured researches published by Toshio Toyosawa.


Infection and Immunity | 2004

Highly purified vitamin B2 presents a promising therapeutic strategy for sepsis and septic shock.

Toshio Toyosawa; Mamoru Suzuki; Kohtarou Kodama; Seiichi Araki

ABSTRACT Highly purified vitamin B2 (riboflavin 5′-sodium phosphate; purity > 97%) treatment by intravenous infusion at doses above those used clinically to treat vitamin B2 deficiency showed therapeutic effects in mice not only in cases of endotoxin- and exotoxin-induced shock but also in cases of gram-negative and gram-positive bacterial infection even after the toxemia had already begun.


Vaccine | 1990

Prophylactic activity of dihydro-heptaprenol, a synthetic polyprenol derivative, against Sendai virus infection in mice

Joji Iida; Chiaki Ishihara; Noriko Mizukoshi; Kyosuke Kitoh; Kazuo Tsukidate; Kanemasa Katsu; Toshio Toyosawa; Ichiro Azuma

Abstract The effect of a chemically synthesized polyprenol derivative, dihydroheptaprenol (DHP), on the non-specific resistance of mice to Sendai virus infection was investigated. The mice that received 200 μg of DHP intranasally twice, at 3 days and 1 day before the infection, showed a significant protection against Sendai virus infection. Treatment of mice twice even with as much as 2000 μg of DHP through the subcutaneous route, however, had no protective effect against infection. Excess interferon and tumour necrosis factor production in intranasally DHP-treated mice was seen 1 day after the infection when compared with Sendai virus alone controls or with DHP alone controls. Variance analysis of these findings indicates a prophylactic activity of DHP in pulmonary viral infections.


Life Sciences | 2005

Inhibitory mechanisms of highly purified vitamin B2 on the productions of proinflammatory cytokine and NO in endotoxin-induced shock in mice.

Kohtarou Kodama; Mamoru Suzuki; Toshio Toyosawa; Seiichi Araki


European Journal of Pharmacology | 2004

Effects of intravenous infusion of highly purified vitamin B2 on lipopolysaccharide-induced shock and bacterial infection in mice

Toshio Toyosawa; Mamoru Suzuki; Kohtarou Kodama; Seiichi Araki


Archive | 1995

Antifungal agents, and compositions

Toshihiko Naito; Katsura Hata; Yumiko Kaku; Akihiko Tsuruoka; Itaru Tsukada; Manabu Yanagisawa; Toshio Toyosawa; Kazumasa Nara


Archive | 1995

Azole antifungal agents, process for the preparation there of and intermediates

Toshihiko Naito; Katsura Hata; Yumiko Kaku; Akihiko Tsuruoka; Itaru Tsukada; Manabu Yanagisawa; Toshio Toyosawa; Kazumasa Nara


European Journal of Pharmacology | 2004

Potentiation by amino acid of the therapeutic effect of highly purified vitamin B2 in mice with lipopolysaccharide-induced shock

Toshio Toyosawa; Mamoru Suzuki; Kohtarou Kodama; Seiichi Araki


Archive | 2003

Drugs containing riboflavin-type compounds

Seiichi Araki; Mamoru Suzuki; Kohtarou Kodama; Toshio Toyosawa


Archive | 1995

Azole antifungal agents, processes for the preparation thereof, and intermediates

Toshihiko Naito; Katsura Hata; Yumiko Kaku; Akihiko Tsuruoka; Itaru Tsukada; Manabu Yanagisawa; Toshio Toyosawa; Kazumasa Nara


Archive | 1995

Intermediates of azole antifungal agents and processes for the preparation thereof

Katsura Hata; Yumiko Nagasaka; Toshihiko Naito; Kazumasa Nara; Toshio Toyosawa; Itaru Tsukada; Akihiko Tsuruoka; Manabu Yanagisawa

Collaboration


Dive into the Toshio Toyosawa's collaboration.

Researchain Logo
Decentralizing Knowledge